Advocat (AVCA)
Advocat Revenue Growth: -0.04%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AVCA Revenue Growth Rankings
| Overall | 32nd percentile | 2962 of 4381 |
| Sector | 29th percentile | 323 of 460 in Healthcare |
| Industry | 23rd percentile | 10 of 13 in Long-Term Care Facilities |
AVCA Revenue Growth Range, Past 5 Years
| Minimum | -29.59% | Dec 2008 |
| Maximum | 41.01% | Dec 2009 |
| Average | 8.86% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these AVCA related companies
AVCA News
Covington Issues Open Letter to Advocat (AVCA) Shareholders Following Rejection of $8.50/Share Bid
May 16, 8:16AM Street Insider
May 16, 8:16AM Street Insider
$AVCA Board Unanimously Rejects Unsolicited Non-Binding Expression of Interest From Covington Investments
about 10 days ago by Benzinga
about 10 days ago by Benzinga
Advocat's Board Unanimously Rejects Unsolicited Non-Binding Expression of Interest From Covington Investments, LLC
May 14, 4:02PM GlobeNewswire
May 14, 4:02PM GlobeNewswire
$AVCA shares up 82% as Covington boosts offer for co. from $7.50/share to $8.50/share
about 13 days ago by Street_Insider
about 13 days ago by Street_Insider
Advocat to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
Apr 30, 4:02PM GlobeNewswire
Apr 30, 4:02PM GlobeNewswire
Advocat to Announce Fourth Quarter 2011 Financial Results on Wednesday, March 7, 2012
Feb 22, 9:00AM GlobeNewswire
Feb 22, 9:00AM GlobeNewswire
Advocat Announces the Opening of Rose Terrace Health and Rehabilitation Center in Culloden, West Virginia
Dec 28, 8:30AM GlobeNewswire
Dec 28, 8:30AM GlobeNewswire
Advocat (AVCA) Announces Resignation of CFO; Sam Daniel Potential Sucessor
Dec 20, 4:06PM Street Insider
Dec 20, 4:06PM Street Insider
Advocat Announces Planned Departure of Chief Financial Officer and the Appointment of Executive Vice President
Dec 20, 4:00PM GlobeNewswire
Dec 20, 4:00PM GlobeNewswire
$AVCA Insider Buy: $119K of stock bought by Covington Health Group, LLC between November 29, 2011 - December 1, 2011 http://stks.co/1TU1
about 167 days ago by MarketBrief
about 167 days ago by MarketBrief
$AVCA Insider Buy: $119K of stock bought by Covington Health Group, LLC between November 29, 2011 - December 1, 2011 http://stks.co/1SHV
about 168 days ago by MarketBrief
about 168 days ago by MarketBrief
$AVCA Insider Buy: $119K of stock bought by Covington Health Group, LLC between November 29, 2011 - December 1, 2011 http://stks.co/1Q4P
about 169 days ago by MarketBrief
about 169 days ago by MarketBrief
$AVCA Insider Buy: $119K of stock bought by Covington Health Group, LLC between November 29, 2011 - December 1, 2011 http://stks.co/1OsZ
about 170 days ago by MarketBrief
about 170 days ago by MarketBrief
$AVCA Insider Buy: $119K of stock bought by Covington Health Group, LLC between November 29, 2011 - December 1, 2011 http://stks.co/1Nf9
about 172 days ago by MarketBrief
about 172 days ago by MarketBrief
$AVCA Insider Buy: $119K of stock bought by Covington Health Group, LLC between November 29, 2011 - December 1, 2011 http://stks.co/1Mso
about 174 days ago by MarketBrief
about 174 days ago by MarketBrief
$AVCA Insider Buy: $119K of stock bought by Covington Health Group, LLC between November 29, 2011 - December 1, 2011 http://stks.co/1Ld2
about 175 days ago by MarketBrief
about 175 days ago by MarketBrief
$AVCA Insider Buy: $348K of stock bought by Covington Health Group, LLC on November 16, 2011 http://stks.co/1CGx
about 188 days ago by MarketBrief
about 188 days ago by MarketBrief
CORRECTING and REPLACING -- Advocat Announces 2011 Third Quarter and Nine Months Results
Nov 07, 6:47PM GlobeNewswire
Nov 07, 6:47PM GlobeNewswire
Today's Dividend-Paying Winners and Losers: http://goo.gl/r2Kam / $AVCA $BAC $PNC $SU $WTI $CASY $BKCC
about 443 days ago by DynamicDividend
about 443 days ago by DynamicDividend
NASDAQ 3 biggest advancers: $BAYN 136.21%, $AVCA 22.62%, $QTWW 20.30%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 972 days ago by datajunkies
about 972 days ago by datajunkies
NASDAQ 3 biggest advancers: $BAYN 136.21%, $AVCA 22.62%, $QTWW 20.30%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 972 days ago by datajunkies
about 972 days ago by datajunkies
NASDAQ 3 biggest advancers: $BAYN 136.21%, $AVCA 22.62%, $QTWW 20.30%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 973 days ago by datajunkies
about 973 days ago by datajunkies
NASDAQ 3 biggest advancers: $BAYN 130.17%, $AVCA 19.01%, $AFFM 16.63%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 973 days ago by datajunkies
about 973 days ago by datajunkies
NASDAQ 3 biggest advancers: $BAYN 131.90%, $OSUR 16.31%, $AVCA 14.07%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 973 days ago by datajunkies
about 973 days ago by datajunkies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AVCA | 6.01 | +0.06 | +1.01% | 34.98M |
| AVA | 25.39 | +0.32 | +1.28% | 1.468B |
| AU | 36.09 | -0.47 | -1.29% | 14.08B |
| ATVI | 12.06 | -0.27 | -2.15% | 13.84B |
| ATV | 3.80 | -0.32 | -7.76% | 113.58M |
| ATRM | 0.59 | -0.01 | -1.67% | 6.468M |
| ATPG | 5.09 | -0.20 | -3.78% | 275.34M |
| ATO | 32.78 | +0.40 | +1.24% | 2.921B |
| ATML | 7.17 | -0.06 | -0.83% | 3.260B |
| ATK | 49.64 | -0.35 | -0.70% | 1.650B |